Industry Research Reports

Home > Reports > Medical Devices & Consumables > Liver Cancer Diagnostic Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Liver Cancer Diagnostic Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-01-24

Pages: 99 Pages

Report ld: 2342170

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Liver Cancer Diagnostic Tests was estimated to be worth US$ 7230 million in 2023 and is forecast to a readjusted size of US$ 12550 million by 2030 with a CAGR of 8.2% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Liver Cancer Diagnostic Tests Market Size

M= millions and B=billions

Report Scope
This report aims to provide a comprehensive presentation of the global market for Liver Cancer Diagnostic Tests, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Liver Cancer Diagnostic Tests by region & country, by Type, and by Application.

The Liver Cancer Diagnostic Tests market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cancer Diagnostic Tests.

Market Segmentation

Report Metric
Details
Report Title
Liver Cancer Diagnostic Tests - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 12550 million
CAGR(2024-2030)
8.2%
Market Size Available for Years
2019-2030
Global Liver Cancer Diagnostic Tests Companies Covered
Abbott Diagnostics, Abcodia, BioMark Technologies, AXO Science SAS, Bioprognos SL, China Sky One Medica, Digna Biotech SL, Glycotest
Global Liver Cancer Diagnostic Tests Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Liver Cancer Diagnostic Tests Market, Segment by Type
Reagent

Instrument
Global Liver Cancer Diagnostic Tests Market, Segment by Application
Hospital

Physical Examination Center

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Liver Cancer Diagnostic Tests manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Liver Cancer Diagnostic Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Liver Cancer Diagnostic Tests in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Liver Cancer Diagnostic Tests Product Introduction
    1.2 Global Liver Cancer Diagnostic Tests Market Size Forecast
        1.2.1 Global Liver Cancer Diagnostic Tests Sales Value (2019-2030)
        1.2.2 Global Liver Cancer Diagnostic Tests Sales Volume (2019-2030)
        1.2.3 Global Liver Cancer Diagnostic Tests Sales Price (2019-2030)
    1.3 Liver Cancer Diagnostic Tests Market Trends & Drivers
        1.3.1 Liver Cancer Diagnostic Tests Industry Trends
        1.3.2 Liver Cancer Diagnostic Tests Market Drivers & Opportunity
        1.3.3 Liver Cancer Diagnostic Tests Market Challenges
        1.3.4 Liver Cancer Diagnostic Tests Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Liver Cancer Diagnostic Tests Players Revenue Ranking (2023)
    2.2 Global Liver Cancer Diagnostic Tests Revenue by Company (2019-2024)
    2.3 Global Liver Cancer Diagnostic Tests Players Sales Volume Ranking (2023)
    2.4 Global Liver Cancer Diagnostic Tests Sales Volume by Company Players (2019-2024)
    2.5 Global Liver Cancer Diagnostic Tests Average Price by Company (2019-2024)
    2.6 Key Manufacturers Liver Cancer Diagnostic Tests Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Liver Cancer Diagnostic Tests Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Liver Cancer Diagnostic Tests
    2.9 Liver Cancer Diagnostic Tests Market Competitive Analysis
        2.9.1 Liver Cancer Diagnostic Tests Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Liver Cancer Diagnostic Tests Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Diagnostic Tests as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Reagent
        3.1.2 Instrument
    3.2 Global Liver Cancer Diagnostic Tests Sales Value by Type
        3.2.1 Global Liver Cancer Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Liver Cancer Diagnostic Tests Sales Value, by Type (2019-2030)
        3.2.3 Global Liver Cancer Diagnostic Tests Sales Value, by Type (%) (2019-2030)
    3.3 Global Liver Cancer Diagnostic Tests Sales Volume by Type
        3.3.1 Global Liver Cancer Diagnostic Tests Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Liver Cancer Diagnostic Tests Sales Volume, by Type (2019-2030)
        3.3.3 Global Liver Cancer Diagnostic Tests Sales Volume, by Type (%) (2019-2030)
    3.4 Global Liver Cancer Diagnostic Tests Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospital
        4.1.2 Physical Examination Center
        4.1.3 Other
    4.2 Global Liver Cancer Diagnostic Tests Sales Value by Application
        4.2.1 Global Liver Cancer Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Liver Cancer Diagnostic Tests Sales Value, by Application (2019-2030)
        4.2.3 Global Liver Cancer Diagnostic Tests Sales Value, by Application (%) (2019-2030)
    4.3 Global Liver Cancer Diagnostic Tests Sales Volume by Application
        4.3.1 Global Liver Cancer Diagnostic Tests Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Liver Cancer Diagnostic Tests Sales Volume, by Application (2019-2030)
        4.3.3 Global Liver Cancer Diagnostic Tests Sales Volume, by Application (%) (2019-2030)
    4.4 Global Liver Cancer Diagnostic Tests Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Liver Cancer Diagnostic Tests Sales Value by Region
        5.1.1 Global Liver Cancer Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Liver Cancer Diagnostic Tests Sales Value by Region (2019-2024)
        5.1.3 Global Liver Cancer Diagnostic Tests Sales Value by Region (2025-2030)
        5.1.4 Global Liver Cancer Diagnostic Tests Sales Value by Region (%), (2019-2030)
    5.2 Global Liver Cancer Diagnostic Tests Sales Volume by Region
        5.2.1 Global Liver Cancer Diagnostic Tests Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Liver Cancer Diagnostic Tests Sales Volume by Region (2019-2024)
        5.2.3 Global Liver Cancer Diagnostic Tests Sales Volume by Region (2025-2030)
        5.2.4 Global Liver Cancer Diagnostic Tests Sales Volume by Region (%), (2019-2030)
    5.3 Global Liver Cancer Diagnostic Tests Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        5.4.2 North America Liver Cancer Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        5.5.2 Europe Liver Cancer Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        5.6.2 Asia Pacific Liver Cancer Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        5.7.2 South America Liver Cancer Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        5.8.2 Middle East & Africa Liver Cancer Diagnostic Tests Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Liver Cancer Diagnostic Tests Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Liver Cancer Diagnostic Tests Sales Value
        6.2.1 Key Countries/Regions Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Liver Cancer Diagnostic Tests Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        6.3.2 United States Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Liver Cancer Diagnostic Tests Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        6.4.2 Europe Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Liver Cancer Diagnostic Tests Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        6.5.2 China Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Liver Cancer Diagnostic Tests Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        6.6.2 Japan Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Liver Cancer Diagnostic Tests Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        6.7.2 South Korea Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Liver Cancer Diagnostic Tests Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        6.8.2 Southeast Asia Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Liver Cancer Diagnostic Tests Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Liver Cancer Diagnostic Tests Sales Value, 2019-2030
        6.9.2 India Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Liver Cancer Diagnostic Tests Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Abbott Diagnostics
        7.1.1 Abbott Diagnostics Company Information
        7.1.2 Abbott Diagnostics Introduction and Business Overview
        7.1.3 Abbott Diagnostics Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Abbott Diagnostics Liver Cancer Diagnostic Tests Product Offerings
        7.1.5 Abbott Diagnostics Recent Development
    7.2 Abcodia
        7.2.1 Abcodia Company Information
        7.2.2 Abcodia Introduction and Business Overview
        7.2.3 Abcodia Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Abcodia Liver Cancer Diagnostic Tests Product Offerings
        7.2.5 Abcodia Recent Development
    7.3 BioMark Technologies
        7.3.1 BioMark Technologies Company Information
        7.3.2 BioMark Technologies Introduction and Business Overview
        7.3.3 BioMark Technologies Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 BioMark Technologies Liver Cancer Diagnostic Tests Product Offerings
        7.3.5 BioMark Technologies Recent Development
    7.4 AXO Science SAS
        7.4.1 AXO Science SAS Company Information
        7.4.2 AXO Science SAS Introduction and Business Overview
        7.4.3 AXO Science SAS Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 AXO Science SAS Liver Cancer Diagnostic Tests Product Offerings
        7.4.5 AXO Science SAS Recent Development
    7.5 Bioprognos SL
        7.5.1 Bioprognos SL Company Information
        7.5.2 Bioprognos SL Introduction and Business Overview
        7.5.3 Bioprognos SL Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Bioprognos SL Liver Cancer Diagnostic Tests Product Offerings
        7.5.5 Bioprognos SL Recent Development
    7.6 China Sky One Medica
        7.6.1 China Sky One Medica Company Information
        7.6.2 China Sky One Medica Introduction and Business Overview
        7.6.3 China Sky One Medica Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 China Sky One Medica Liver Cancer Diagnostic Tests Product Offerings
        7.6.5 China Sky One Medica Recent Development
    7.7 Digna Biotech SL
        7.7.1 Digna Biotech SL Company Information
        7.7.2 Digna Biotech SL Introduction and Business Overview
        7.7.3 Digna Biotech SL Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Digna Biotech SL Liver Cancer Diagnostic Tests Product Offerings
        7.7.5 Digna Biotech SL Recent Development
    7.8 Glycotest
        7.8.1 Glycotest Company Information
        7.8.2 Glycotest Introduction and Business Overview
        7.8.3 Glycotest Liver Cancer Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Glycotest Liver Cancer Diagnostic Tests Product Offerings
        7.8.5 Glycotest Recent Development

 8 Industry Chain Analysis
    8.1 Liver Cancer Diagnostic Tests Industrial Chain
    8.2 Liver Cancer Diagnostic Tests Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Liver Cancer Diagnostic Tests Sales Model
        8.5.2 Sales Channel
        8.5.3 Liver Cancer Diagnostic Tests Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Liver Cancer Diagnostic Tests Market Trends
    Table 2. Liver Cancer Diagnostic Tests Market Drivers & Opportunity
    Table 3. Liver Cancer Diagnostic Tests Market Challenges
    Table 4. Liver Cancer Diagnostic Tests Market Restraints
    Table 5. Global Liver Cancer Diagnostic Tests Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Liver Cancer Diagnostic Tests Revenue Market Share by Company (2019-2024)
    Table 7. Global Liver Cancer Diagnostic Tests Sales Volume by Company (2019-2024) & (Units)
    Table 8. Global Liver Cancer Diagnostic Tests Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Liver Cancer Diagnostic Tests Price by Company (2019-2024) & (K USD/Unit)
    Table 10. Key Manufacturers Liver Cancer Diagnostic Tests Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Liver Cancer Diagnostic Tests Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Liver Cancer Diagnostic Tests
    Table 13. Global Liver Cancer Diagnostic Tests Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Diagnostic Tests as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Liver Cancer Diagnostic Tests Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Liver Cancer Diagnostic Tests Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Liver Cancer Diagnostic Tests Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Liver Cancer Diagnostic Tests Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Liver Cancer Diagnostic Tests Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Liver Cancer Diagnostic Tests Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)
    Table 22. Global Liver Cancer Diagnostic Tests Sales Volume by Type (2019-2024) & (Units)
    Table 23. Global Liver Cancer Diagnostic Tests Sales Volume by Type (2025-2030) & (Units)
    Table 24. Global Liver Cancer Diagnostic Tests Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Liver Cancer Diagnostic Tests Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Liver Cancer Diagnostic Tests Price by Type (2019-2024) & (K USD/Unit)
    Table 27. Global Liver Cancer Diagnostic Tests Price by Type (2025-2030) & (K USD/Unit)
    Table 28. Global Liver Cancer Diagnostic Tests Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Liver Cancer Diagnostic Tests Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Liver Cancer Diagnostic Tests Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Liver Cancer Diagnostic Tests Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Liver Cancer Diagnostic Tests Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Liver Cancer Diagnostic Tests Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)
    Table 34. Global Liver Cancer Diagnostic Tests Sales Volume by Application (2019-2024) & (Units)
    Table 35. Global Liver Cancer Diagnostic Tests Sales Volume by Application (2025-2030) & (Units)
    Table 36. Global Liver Cancer Diagnostic Tests Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Liver Cancer Diagnostic Tests Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Liver Cancer Diagnostic Tests Price by Application (2019-2024) & (K USD/Unit)
    Table 39. Global Liver Cancer Diagnostic Tests Price by Application (2025-2030) & (K USD/Unit)
    Table 40. Global Liver Cancer Diagnostic Tests Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Liver Cancer Diagnostic Tests Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Liver Cancer Diagnostic Tests Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Liver Cancer Diagnostic Tests Sales Value by Region (2019-2024) & (%)
    Table 44. Global Liver Cancer Diagnostic Tests Sales Value by Region (2025-2030) & (%)
    Table 45. Global Liver Cancer Diagnostic Tests Sales Volume by Region (Units): 2019 VS 2023 VS 2030
    Table 46. Global Liver Cancer Diagnostic Tests Sales Volume by Region (2019-2024) & (Units)
    Table 47. Global Liver Cancer Diagnostic Tests Sales Volume by Region (2025-2030) & (Units)
    Table 48. Global Liver Cancer Diagnostic Tests Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Liver Cancer Diagnostic Tests Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Liver Cancer Diagnostic Tests Average Price by Region (2019-2024) & (K USD/Unit)
    Table 51. Global Liver Cancer Diagnostic Tests Average Price by Region (2025-2030) & (K USD/Unit)
    Table 52. Key Countries/Regions Liver Cancer Diagnostic Tests Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Liver Cancer Diagnostic Tests Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Liver Cancer Diagnostic Tests Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Liver Cancer Diagnostic Tests Sales Volume, (2019-2024) & (Units)
    Table 56. Key Countries/Regions Liver Cancer Diagnostic Tests Sales Volume, (2025-2030) & (Units)
    Table 57. Abbott Diagnostics Company Information
    Table 58. Abbott Diagnostics Introduction and Business Overview
    Table 59. Abbott Diagnostics Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)
    Table 60. Abbott Diagnostics Liver Cancer Diagnostic Tests Product Offerings
    Table 61. Abbott Diagnostics Recent Development
    Table 62. Abcodia Company Information
    Table 63. Abcodia Introduction and Business Overview
    Table 64. Abcodia Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)
    Table 65. Abcodia Liver Cancer Diagnostic Tests Product Offerings
    Table 66. Abcodia Recent Development
    Table 67. BioMark Technologies Company Information
    Table 68. BioMark Technologies Introduction and Business Overview
    Table 69. BioMark Technologies Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)
    Table 70. BioMark Technologies Liver Cancer Diagnostic Tests Product Offerings
    Table 71. BioMark Technologies Recent Development
    Table 72. AXO Science SAS Company Information
    Table 73. AXO Science SAS Introduction and Business Overview
    Table 74. AXO Science SAS Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)
    Table 75. AXO Science SAS Liver Cancer Diagnostic Tests Product Offerings
    Table 76. AXO Science SAS Recent Development
    Table 77. Bioprognos SL Company Information
    Table 78. Bioprognos SL Introduction and Business Overview
    Table 79. Bioprognos SL Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)
    Table 80. Bioprognos SL Liver Cancer Diagnostic Tests Product Offerings
    Table 81. Bioprognos SL Recent Development
    Table 82. China Sky One Medica Company Information
    Table 83. China Sky One Medica Introduction and Business Overview
    Table 84. China Sky One Medica Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)
    Table 85. China Sky One Medica Liver Cancer Diagnostic Tests Product Offerings
    Table 86. China Sky One Medica Recent Development
    Table 87. Digna Biotech SL Company Information
    Table 88. Digna Biotech SL Introduction and Business Overview
    Table 89. Digna Biotech SL Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)
    Table 90. Digna Biotech SL Liver Cancer Diagnostic Tests Product Offerings
    Table 91. Digna Biotech SL Recent Development
    Table 92. Glycotest Company Information
    Table 93. Glycotest Introduction and Business Overview
    Table 94. Glycotest Liver Cancer Diagnostic Tests Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)
    Table 95. Glycotest Liver Cancer Diagnostic Tests Product Offerings
    Table 96. Glycotest Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Liver Cancer Diagnostic Tests Downstream Customers
    Table 100. Liver Cancer Diagnostic Tests Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Liver Cancer Diagnostic Tests Product Picture
    Figure 2. Global Liver Cancer Diagnostic Tests Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Liver Cancer Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Liver Cancer Diagnostic Tests Sales Volume (2019-2030) & (Units)
    Figure 5. Global Liver Cancer Diagnostic Tests Sales Price (2019-2030) & (K USD/Unit)
    Figure 6. Liver Cancer Diagnostic Tests Report Years Considered
    Figure 7. Global Liver Cancer Diagnostic Tests Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Liver Cancer Diagnostic Tests Players Sales Volume Ranking (2023) & (Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Liver Cancer Diagnostic Tests Revenue in 2023
    Figure 10. Liver Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Reagent Picture
    Figure 12. Instrument Picture
    Figure 13. Global Liver Cancer Diagnostic Tests Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Liver Cancer Diagnostic Tests Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Liver Cancer Diagnostic Tests Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)
    Figure 16. Global Liver Cancer Diagnostic Tests Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Liver Cancer Diagnostic Tests Price by Type (2019-2030) & (K USD/Unit)
    Figure 18. Product Picture of Hospital
    Figure 19. Product Picture of Physical Examination Center
    Figure 20. Product Picture of Other
    Figure 21. Global Liver Cancer Diagnostic Tests Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Liver Cancer Diagnostic Tests Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Liver Cancer Diagnostic Tests Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)
    Figure 24. Global Liver Cancer Diagnostic Tests Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Liver Cancer Diagnostic Tests Price by Application (2019-2030) & (K USD/Unit)
    Figure 26. North America Liver Cancer Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Liver Cancer Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Liver Cancer Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Liver Cancer Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Liver Cancer Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Liver Cancer Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Liver Cancer Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Liver Cancer Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Liver Cancer Diagnostic Tests Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Liver Cancer Diagnostic Tests Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Liver Cancer Diagnostic Tests Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Liver Cancer Diagnostic Tests Sales Volume (%), (2019-2030)
    Figure 38. United States Liver Cancer Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Liver Cancer Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Liver Cancer Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Liver Cancer Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Liver Cancer Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Liver Cancer Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Liver Cancer Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Liver Cancer Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Liver Cancer Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Liver Cancer Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Liver Cancer Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Liver Cancer Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Liver Cancer Diagnostic Tests Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Liver Cancer Diagnostic Tests Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Liver Cancer Diagnostic Tests Sales Value by Application (%), 2023 VS 2030
    Figure 59. Liver Cancer Diagnostic Tests Industrial Chain
    Figure 60. Liver Cancer Diagnostic Tests Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

Description

The global market for Liver Cancer Diagnostic Tests was estimated to be worth US$ 7230 million in 2023 and is forecast to a readjusted size of US$ 12550 million by 2030 with a CAGR of 8.2% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Liver Cancer Diagnostic Tests, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Liver Cancer Diagnostic Tests by region & country, by Type, and by Application.

The Liver Cancer Diagnostic Tests market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Cancer Diagnostic Tests.

Market Segmentation